In our human xenograft models, FAP-CAR T cells did not lose activity in the NCG tumor microenvironment, suggesting that through elimination of FAP-positive stroma cells could FAP-CAR T cells limit the tumor growth. The gene discussed is FAP; the disease is neoplasm.